Oncoment Biotechnology is a company operating in the field of personalized cancer treatment, initially launching its commercial activities with a chemosensitivity test. This test, performed on the patient's own tumor tissue, aims to identify the most effective chemotherapy drug. Compared to similar methods worldwide, it is more affordable and provides faster results.
In addition to its core service, the company offers project development and wet lab services in oncology to other research firms and healthcare institutions. Oncoment continues to grow through new and innovative R&D programs.
Phone: +90 (540) 143 6053
Mail: oncoment2020@gmail.com